课题基金 / 基金详情

ACTG 248--PHASE II STUDY OF IL 2 BY SUBCUTANEOUS INJECTION OF HIV/ANTIRETROVIRAL

ACTG 248--PHASE II STUDY OF IL 2 BY SUBCUTANEOUS INJECTION OF HIV/ANTIRETROVIRAL
ACTG 248--通过皮下注射 HIV/抗逆转录病毒药物进行 IL 2 的 II 期研究
批准号:
6122125
负责人:
Juan J. L. Lertora
金额:
$1.12万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-19 至 1999-11-30

项目摘要

项目成果

Juan J. L. Lertora的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a multi center, randomized, open label trial of low dose IL-2 in combination with continued antiretroviral (ARV) therapy vs. ARV therapy alone in HIV+ males and females, ages 18 and older with CD4 cell counts between 300 and 700 cells/mm3 and a stable ARV regimen for at least 2 months prior to study entry. Subjects may not have had a previous AIDS defining diagnosis. This study seeks to determine whether the replacement of IL-2 may help restore anti-HIV immunity in addition to overall immune competence and responses to routine protein and/or polysaccharide vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL EVALUATION OF FLOWABLE COMPOSITE RESIN
  • 批准号:
    7376290
  • 项目类别:
  • 资助金额:
    $0.12万
  • 财政年份:
    2005
  • 负责人:
    Juan J. L. Lertora
  • 依托单位:
TRIAL OF TWO POTENT, SIMPLIFIED REGIMENS UTILIZING A PROTEASE INHIBITOR-SPARING
  • 批准号:
    7204089
  • 项目类别:
  • 资助金额:
    $1.11万
  • 财政年份:
    2004
  • 负责人:
    Juan J. L. Lertora
  • 依托单位:
QUALITY ASSESSMENT STUDY FOR VIABLE PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC)
  • 批准号:
    7203980
  • 项目类别:
  • 资助金额:
    $0.16万
  • 财政年份:
    2004
  • 负责人:
    Juan J. L. Lertora
  • 依托单位:
Study of Prolongation of Virologic Success and Options From Failure in HIV
  • 批准号:
    7043959
  • 项目类别:
  • 资助金额:
    $0.36万
  • 财政年份:
    2003
  • 负责人:
    Juan J. L. Lertora
  • 依托单位:
海外基金